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The 2B proteins of coxsackievirus and poliovirus
(PV) share significant structural similarity and exhibit
similar biochemical activities, namely inhibition of 
protein secretion and modification of membrane 
permeability. Both proteins contain two hydro- 
phobic domains in the carboxy-terminal two-thirds 
of their sequence, of which one has the potential to 
form a cationic amphipathic a-helix. To gain more 
insight into the structural requirements of entero­
virus protein 2B for its functioning in viral RNA 
replication, a chimeric cDNA approach was used. 
Chimeric coxsackie B3 virus (CBV3) genomes were 
constructed that expressed either the entire PV 2B 
protein or hybrid proteins in which specificsegments 
ofCBV3 2B were substituted by their corresponding 
PV counterparts, in vitro synthesis and processing of 
the chimeric polyproteins showed no abnormalities.
Introduction _____________________________
The genus Enterovirus of the family of Picornaviridae, a large 
group of plus-strand RNA viruses, comprises polioviruses 
(PV), coxsackie A viruses, coxsackie B viruses (CBV), echo- 
viruses, and several distinct enteroviais serotypes. These 
enteroviruses are closely related and share marked similarities 
with respect to virus structure, genomic organization and 
replicative cycle (Wimmer et al, 1993). The main differences 
between these viruses are observed in the clinical syndromes 
they produce in humans, growth in particular cell lines, and the 
illness and pathology they, produce in monkeys and suckling 
mice (Melnick, 1996). The differences in tropism are pre­
dominantly based on the ability to bind to specific receptors 
for cell entry, reflecting differences in the structural capsid 
proteins encoded by the P i region of the genome, and the
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CBV3 genomes carrying the entire PV 2B gene 
failed to replicate. A chimeric genome that expressed 
a hybrid 2B protein consisting of the amino-terminal 
one-third of PV and the remainder of CBV3 yielded 
viable viruses. In contrast, a 2B protein consisting of 
the amino-terminal one-third of CBV3 and the 
remainder of PV failed to drive replication. These 
data imply that a sequence-specific interaction with 
another viral protein is required to drive RNA 
replication and suggest that the proposed sites of 
contact reside in the carboxy-terminal two-thirds of 
2B. Hybrid genomes in which either the amphipathic 
a-helix or the other hydrophobic domain was re­
placed failed to replicate. The potential contribution 
of these domains to the structure and functioning of 
protein 2B are discussed.
occurrence of host-specific cis-acting translational control 
elements in the genomic RNA (Agol et al, 1996; Racaniello, 
1990).
The enteroviruses can be divided into seven clusters, based 
on properties of genotype and function (Hyypia et al.r 1997). 
CBV serotypes 1—6 and PV serotypes 1—3 fall into different 
clusters. The nonstructural proteins encoded by the P2 and P3 
regions of the genomes of CBV and PV share 50 to 65 % amino 
acid identity. Despite the differences in primary sequence, 
there is a high degree of conservation of important structural 
domains and sequence motifs, suggesting that these proteins 
share similar functions in virus reproduction. Studies on the 
functional exchangeability of these proteins have provided 
experimental evidence for this suggestion. Chimeric PV 
genomes containing the coxsackie B3 virus (CBV3) counterpart 
of protein 3Cpro, a proteinase that is responsible for the 
majority of the processing events that give rise to the 
production of the nonstructural proteins, demonstrated correct 
processing of the PV P2 and P3 region proteins (Dewait et ai,
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1989). In addition, PV genom es carrying CBV4 protein 2ApI°, 
a multifunctional protein that acts as a proteinase, a trans- 
activator of virus translation and as a component in viral RNA 
(vRNA) replication, gave rise to viable viruses (Lu et al., 1995).
Enterovirus protein 2B is a small hydrophobic protein that 
is localized at the outer surface of the membrane vesicles on 
which vRNA replication takes place (Bienz et ah, 1994). The 
phenotypes of 2B mutants of both PV and CBV3 have implied 
a role of protein 2B, or possibly its precursor 2BC in vRNA  
amplification (Johnson & Sarnow, 1991; Li & Baltimore, 1988; 
van Kuppeveld et al, 1995, 1996 a, b). The exact function of 
this protein is not yet unclear but seems to be related to its 
effects on cellular membranes. Expression of the 2B proteins of 
both PV and CBV3 in mammalian cells caused a modification 
in permeability of the plasma membrane and inhibition of 
vesicular protein transport (Doedens & Kirkegaard, 1995; van 
Kuppeveld et al, 1997«), two phenomena that also occur 
during enterovirus infection (Carrasco et ah, 1993; Doedens & 
Kirkegaard, 1995). Recently, CBV3 protein 2B has also been 
shown to increase the permeability of the endoplasmic 
reticulum membrane (van Kuppeveld et al, 1997 b)r The 
interaction of enterovirus protein 2B with membranes is most 
likely provided by the tw o conserved hydrophobic domains, 
of which one has the potential to form a cationic amphipathic 
a-helix (van Kuppeveld et al, 1996 a) and one (which will 
further be referred to as 'the second hydrophobic domain") 
shows characteristics typical of multimeric transmembrane 
helices (van Kuppeveld et al, 1995). The relevance of these 
domains for the ability of CBV3 2B to increase membrane 
permeability and inhibit protein secretion has been confirmed 
by individual expression of 2B proteins carrying mutations in 
these regions (van Kuppeveld et al., 1997a, b).
The aim of this study was to gain more insight into the 
structural requirements o f enterovirus protein 2B for its 
function in virus reproduction. To this end, we have con­
structed chimeric CBV3 cD N A s that contained either the 
entire PV 2B protein or hybrid proteins in which specific 
segments of CBV3 protein 2B were substituted by the 
corresponding PV regions. The ability of PV 2B and the hybrid 
2B proteins to drive vR N A  replication and virus growth was 
assayed by transfection of cells with copy RNA transcripts of 
the chimeric cDNAs. Polyprotein synthesis and processing 
were studied by translation of RNA transcripts in a cell-free 
extract. The potential contribution of the distinct domains to 
the structure and function of protein 2B are discussed.
Methods _________________________________
■  Construction of unique endonuclease restriction sites in 
pCB3/T7 . For the introduction of PV sequences into plasmid p C B 3 /T 7 
(Klump et al., 1990), which contains a cD N A  of CBV3 (strain Nancy) 
behind a T7 RNA polymerase prom oter, unique restriction sites were 
introduced, either alone or in combination, by  site-directed mutagenesis. 
Mutagenesis was performed with a subgenomic pALTER phagemid 
clone containing the EcoRV fragm ent o f p C B 3 /T 7  [nucleotide (nt)
918-6177] using the Altered Sites in vitro mutagenesis system according 
to the manufacturer's instructions (Promega). The nucleotide sequence of 
the antisense synthetic oligonucleotides (Isogen Bioscience, The Neth­
erlands) used for the introduction of unique restriction sites (underlined) 
immediately upstream or downstream of the 2B-encoding sequence are; 
5' TTCC AC AT AGTCCTT CAAGGCCTGTT CCATTGC AT C 3' (SM 
site at nt 3743) and 5 ' TTTCTTAAGCCAGCTGTTAACTTGGCG-
TTCAGCCAT 3' {Hpal site at nt 4042), Nucleotide sequences of the 
oligonucleotides used for the introduction of unique restriction sites at 2B
amino acids (aa) 57—59 are; 5 f TAGTGTGGCAGTCACAGTGAT- 
CA G G TCG TG G TICCG G A CCA CA ATTA CTA A G G CTG  ATAT 3' 
{Acclll site at nt 3913) and 5 ' G A TCAG G TCA TCG TG GTTAACC- 
ACCACAA TTACTAAGGC 3 ' (Hpal site at nt 3915). M utant pALTER 
clones were identified by restriction enzyme analysis. The nucleotide 
sequence of the mutant clones was verified by dideoxy chain-termination 
sequencing of plasmid D N A  using the Ampli Cycle sequencing kit 
according to the manufacturer's instructions (Perkin-Elmer). The unique 
restriction sites were introduced in pC B 3/T 7 by cloning of the Bglll 
(nt 2G40)-BssHII (4238) fragments in plasmids from which the corr­
esponding fragment was deleted. In this way, plasmids pCB3/T7- 
Sf 141(3743), pCB3/T7-Hp«I(4042), pCB3/T7-HpaI(3915), pCB3/T7-SfoI- 
(3743)/Hpal(4042), pCB3/T7-SfwI(3743)/Hj;flI(3915) and pCB3/T7- 
AccIII(3913)/H/?i?I(4042) were generated.
■  Construction of chimeric cDNAs, Chimeric cDNAs were con­
structed by PCR amplification and cloning of PV 2B~encoding segments 
into pCB3/T7 plasmids from which the corresponding segment was 
deleted. Plasmid pXpA (generously provided by R. Andino, University of 
California), which contains a cDNA of PV type 1, was used as template 
for PCR. A  total of four forward primers (fl~f4) and five reverse primers 
(rl-rS) containing restriction sites at their 5' end (underlined) were used 
for amplifying PV sequences. PCR was performed using SuperTaq DNA 
polymerase (HT Biotechnology) according to the manufacturer's instruc­
tions. The chimeric cDNAs were named according to the CBV3 amino 
acids that were replaced by the corresponding residues of PV, The 
construction of each of the chimeric plasmids is briefly summarized:
2B /PV l-99; a D N A  fragment containing the coding sequence of PV 
aa 1-99  was generated by PCR using primers f l  (5' ATGGAAC- 
TG C G C AT C AC C AATTAC AT A  3 '; A vili  site) and r l  (5' CCAACT- 
AATATTTTGCTTGATGACATAAGG 3 ';  Sspl site), digested 
with A vill  and Sspl, and cloned in pCB3/T7-SM(3743)/ 
Hpal(4042) from which the Stul—Hpal fragment was deleted.
2B/PV1-94; a D N A  fragment containing the coding sequence of PV 
aa 1-94  was generated by PCR using primers f l  and r2 (5' 
C C A ACT AAT A TTTT G G C G TTC AG CC ATAG GT A T CT CC AG AAC- 
ATCGCA 3'; Sspl site), digested with .Auill and Sspl, and cloned in 
pCB3/T7-SM(3743)/H/?flI(4042) from which the Stul—Hpal fragment 
was deleted.
2B/PV1-30; a DNA fragment containing the coding sequence of PV 
aa 1—30 was generated by  PCR using primers f l  and r3 (5 
GGTACTGA CTA GTGAATTGGTCAACTCTGTTAT 3 '; SpeI site), 
digested with A vill  and Spel, and cloned in pCB3/T7-Sf«I(3743) from 
which the Stul—Spel (3837) fragment was deleted.
2B/PV1-59; a D N A  fragment containing the coding sequence of PV 
aa 1—59 was generated by PCR using primers f l  and r4 (5' TTCATA- 
AGGCCTAGTTATAATAACTAG 3 ';  Stul site), digested with Avill 
and Stul, and cloned in pCB3/T7-SM (3743)/HpaI(3915) from which the 
Stul-Hpal fragment was deleted.
2B/PV60-99; a D N A  fragment containing the coding sequence of PV 
aa 60—99 was generated by PCR using primers f2 (5/ ATTATAA- 
IC CG G A A CTA TG A A G A CA CC  3 '; Acclll site) and r l ,  digested with
Acclll and Sspl and cloned in pCB3/T7-/\ccIII(3913)/HpiiI(4042)
from which the A cdU -H pal  fragment was deleted.
2B/PV60-94; a D N A  fragment containing the coding sequence of PV 
aa 60-94 was generated by  PCR using primers f2 and r2, digested with 
Acclll and Sspl, and cloned in pCft3/T7-Acdll(3913)/H pal{4042)  from 
which the Acclll—Hpal fragment was deleted.
2B/PV34-59; a D N A  fragment containing the coding sequence of PV 
aa 34-59 was generated by PCR using primers f3 (5' AATAT- 
GCTAGCCAGTACCATCACTGAA 3'; Nhel site) and r4, digested 
with Nhel and Stul, and cloned in pCB3/T7-H/?«I(3915) from which 
the Spel (3S37)-tIpal fragment was deleted. Due to the occurrence of 
a Spel site in the amplicon, a Nhel site (compatible ends with Spel) was 
build in the 5' end of primer f3. As result of this, valine 33 is altered to 
alanine.
2B/PV34-99; a D N A  fragment containing the coding sequence of PV 
aa 34-99 was generated by PCR using primers f3 and rl, digested with 
Nhel and Sspl, and cloned in pCB3/T7-H^fll(4042) from which the Spel 
(3837)-HpflI fragment was deleted. Due to the occurrence of a Nhel site 
rather than a Spel site in primer f3 (see above), valine 33 is changed to 
alanine.
2B/PV34-94; a D N A  fragment containing the coding sequence of PV 
aa 34-94 was generated by  PCR using primers f3 and r2, digested with 
Nhel and Sspl, and cloned in pCB3/T7-H/7£?I(4042) from which the Spel 
{3$37)-Hpal fragment was deleted. Due to the occurrence of a Nhel site 
rather than a Spel site in primer f3 (see above), valine 33 is changed to 
alanine.
2B/PV37-54; a D N A  fragment containing the coding sequence 
of PV aa 37—54 was generated by PCR using primers f4 (5' GAG-
TTGTCA CTA GTG G G TCA A G A C A CCA TC A CTG A A A A G C TA CT- 
TAAG-3'; Spel site) and r5 (5' TTCATAA G G C C T CACCACAAT- 
AACTAGGGAGGATATGATCTT 3 ';  Stul site), digested with Spel 
and Stul, and cloned in pC B3/T7-H pal(3915)  from which the Spel 
{3837)-HpaI fragment was deleted. Primer r5 was designed such that 
the Spel site occurring in the PV sequence was deleted while leaving the 
amino acid sequence intact.
From all mutant constructs, the entire PV segment that was introduced 
was confirmed by sequence analysis.
■ Transfection of cells with copy RNA transcripts. In vitro 
transcription of Sail linearized plasmids by phage T7 RNA polymerase 
and transfection of 75% confluent Buffalo green monkey (BGM) cell 
monolayers with RNA transcripts (5 ng) using the DEAE-dextran method 
were performed as described previously (van Kuppeveld et a l,  1995). 
After transfection, cells were fed with minimal essential medium (MEM) 
containing 10% foetal bovine serum (FBS) and incubated at either 33 or 
36 °C. If virus grow th was observed  cultures were incubated until 
cytopathic effect (CPE) was complete, followed by three cycles of 
freezing and thawing to release intracellular viruses. Viruses were 
aliquoted and stored at —80 °C.
■  Analysis of RNA synthesis by dot blot hybridization. BGM
cell monolayers were transfected with wild-type and mutant RNA 
transcripts as described above. At various times post-transfection, the 
medium was discarded and the cells were washed three times with PBS. 
Total RNA was isolated by a single extraction procedure with guanidium 
thiocyanate—phenol—chloroform as described by Chomczynski & Sacchi
(1987). RNAs were denatured with formamide and formaldehyde and 
spotted onto Hybond nylon membranes (Amersham) according to 
standard procedures (Ausubel, 1990). cDNA clone pCB3/T7 was labelled 
with [a-32P]dATP by nick-translation. Membranes were prehybridized, 
hybridized, washed, and analysed by autoradiography according to 
standard procedures (Ausubel, 1990).
M  In v i tro  translation reactions. C opy RNA transcripts were 
synthesized and translated in a single reaction using T7 T n T  rabbit 
reticulocyte lysate (Promega) supplemented with 20%  (v /v ) HeLa cell 
initiation factors (kindly provided by  J. Flanegan, University of Florida). 
The translation reactions (20 j.d) contained 0'5 jag of circular plasmid 
DNA and 20 f.iCi of T ran35S-label (a mixture of [3&S]methionine and 
[,Ji>S]cysteme; ICN) and were incubated for 3 h  at 30 °C. Translation 
products were analysed on an SDS—12-5 % polyacrylamide gel (Laemmli, 
1970). Gels were fixed, fluorographed and exposed to Kodak XAR film at
- 8 0  ° C
B  Sequence verification of virus. RNA extraction, synthesis of 
cDNA, amplification of the 2B coding region by  PCR using primers 5' 
T G G T G T C A T T G G C A T T G T G A C C A T G G G G G G  3 ' (nt 3648-3677) 
and 5' T T G G G A T G G C G C G C TC T G C T C  3 ' (nt 4231-4251), purifica­
tion of the PCR products, and sequence analysis with reverse primer 5' 
CCA TTCA A TG A A TTTCTG  3 ' (nt 4117—4134) were all performed as 
described previously (van Kuppeveld et a!., 1996 a).
■  Virus titrations. Virus titres were determined by endpoint titration 
as described previously (van Kuppeveld et a l, 1995) and expressed in 
50%  tissue culture infective doses (TCID50) according to the m ethod of 
Reed & M uench (1938).
■  Single-cycle growth analysis. Confluent BGM cell monolayers 
grow n in 25 cm2 flasks (5 x  10fi cells) were infected with virus at an m.o.i. 
of 1 TCID50 per cell for 30 min at room  temperature. The cells were fed 
with M EM  containing 3 % FBS and g row n  at 33, 36 or 39 °C. A t various 
times post-infection, cells were disrupted by  three cycles of freezing and 
thawing, and the virus titres w ere determined.
M  Analysis of viral protein synthesis in  v i v o , Confluent m ono­
layers of BGM cells were infected with virus at an m.o.i. of 25 for 30 min 
at room temperature. After infection, cells were fed with M E M  containing 
3 % FBS and grow n at 36 °C. A t various times post-infection, the cells 
were washed with PBS and incubated in methionine- and serum-free 
MEM (Gibco) containing 10 p.Ci of T ran35S-label for 30 min. Lysis of cells 
and analysis of the [35S]methionine-labelled proteins by SDS—PAGE were 
performed as previously described (van Kuppeveld et a l, 1995).
Results __________________________________
Construction of heterologous CBV3 cDNAs
To allow the construction of chimeric CBV3 genomes, 
unique restriction sites were introduced, either alone or in 
combination, at the 2A /2B  and 2B /2C  junctions and within 
the 2B coding sequence of plasmid pCB3/T7. PV sequences 
were amplified by  PCR and cloned in these constructs. PCR 
primers were designed such that no additional amino acid 
changes outside the substituted fragment were introduced. A  
total of ten chimeric constructs, schematically diagrammed in 
Fig. 1, was generated. In construct 2B/PV 1-99, the complete 
2B coding region of CBV3 was replaced by that of PV. In the 
other constructs, the amino-terminal region (i.e. the first 30—35 
amino acids), the amphipathic a-helix, or the second hydro­
phobic domain were replaced, either alone or in combination, 
by their corresponding PV counterparts. Because the borders 
of the amphipathic a~helix are not known exactly, two different 
constructs (2B /PV 34-59 and 2B/PV 37-54) were generated. 
Constructs 2B /PV 1-99, 2B /PV 60-99 and 2B /PV 34-99 con­
tained at the P4 position of the 2B /2C  cleavage site a valine
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Fig, 1. Schematic representation of the chimeric CBV3 genomes. At the top of the figure is shown the 7-5 kb single-stranded 
RNA genome of CBV3 with the polyadenylate tract at the end of the 3' nontranslated region (NTR). The boxed region shows 
the polyprotein and vertical lines within the box indicate proteinase cleavage sites. The complete amino acid sequence of 
protein 2B, containing the cationic amphipathic a-helix and the second hydrophobic domain, is enlarged. The poliovirus 2B 
encoding segments are shaded.
rather than an alanine (which occurs in wild-type CBV3). 
Therefore, three additional constructs (2B/PV1-94, 2B/PV60- 
94 and 2B/PV34-94) containing the last five amino acids of 
CBV3 2B were generated as well.
Viability of chimeric CBV3 genomes
To examine whether PV protein 2B and the hybrid 
PV-CBV3 2B proteins could functionally replace the 2B 
protein of CBV3 in vivo, BGM cells were transfected with in 
vitro synthesized RNA transcripts from wild-type pCB3/T7 
and the chimeric constructs. Four transfections were performed 
for each construct. Two transfected cell cultures were grown at 
33 C and two were grown at 36 °C. If no virus growth was 
observed after 5 days, the cultures were subjected to three 
cycles of freezing and thawing, and passaged to fresh cell 
cultures, which were incubated for an additional 3 days.
Transfection of cells with RNA transcripts derived from the 
wild-type plasmid gave complete CPE within 2 days. RNA 
transcripts from construct 2B/PV1-30 produced CPE in all
transfected cell cultures at 5 days post-transfection. Sequence 
analysis of the 2B coding region of this virus (vCB3-2B/PVl- 
30) showed that the introduced PV segment was retained and 
that no other mutations had occurred. N o CPE was observed 
in any of the cell cultures that were transfected with RNA of 
the other chimeras, Passage of cytoplasmic extracts to fresh 
BGM cell monolayers also failed to reveal virus growth.
Analysis of the virus growth of vCB3-2B/PVl-30 in a 
single-cycle infection showed a delay in virus production 
relative to wild-type virus (Fig. 2). This delay was most 
apparent at 6 h post-infection, when mutant virus production 
was only 1% of that of wild-type virus. The delay in virus 
growth was not temperature sensitive; the kinetics of virus 
reproduction of vCB3-2B/PVl-30 relative to that of wild-type 
virus was similar at 33, 36 and 39 °C (data not shown).
Analysis of vRNA replication
To examine whether the reduced growth of vCB3-2B/PVl- 
30 and the nonviability of the other chimeric genomes were
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. 3. Analysis of wild-type and mutant viral RNA replication. BGM cell 
monolayers were transfected with equal amounts of genomic transcripts 
derived from the indicated plasmids linearized by So/1. At the indicated
times post-transfection, total RNA was isolated, denatured, bound to nylon 
membrane and hybridized to an a-32P-label!ed cDNA probe.
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CBV3 genomes that express hybrid CBV3-PV 2B proteins
exchangeability  of th e  2 A pro and 3 C pro proteins of PV
with those of CBVs (Dewalt et al, 1989; Lu et al, 1995) 
and the overall similarity in structure of the nonstructural 
enterovirus proteins are further indicative of a conservation 
of the functions of these proteins. Alternative expla­
nations for the non-exchangeability of protein 2B must 
therefore be considered. A possible cause for the defect in 
vRNA replication of this chimera may be the heterologous 
nature of protein 2BC, a relatively stable processing in­
termediate that is required for the induction of the membrane 
vesicles on which vRNA amplification takes place (Barco & 
Carrasco, 1995; Bienz et al, 1983). Impaired functioning of a 
heterologous precursor protein was also observed with PV 
chimeras that contained 3Cpro of either human rhino virus 14 or 
CBV3. These 3C proteinases were able to cleave the non­
structural precursor polypeptides, but the hybrid 3CDpro 
proteins were unable to process the PV capsid proteins 
(Dewalt et al, 1989). Another possible explanation for the 
inability of PV 2B to drive vRNA synthesis may be a failure to 
recognize and contact other CBV3 replication proteins. Thus, 
apart from its ability to modify membrane permeability and 
inhibit protein secretion, protein 2B may play a direct role in 
vRNA replication in which interactions with other viral 
proteins are essential. This suggestion is consistent with the 
existence of mutations that interfere with vRNA replication 
but that do not impair the ability of 2B to increase membrane 
permeability or inhibit protein secretion (van Kuppeveld et al.,
1997 a).
Only one of the hybrid 2B proteins was functional in 
vRNA replication. This hybrid protein (2B/PV1-30) contained 
the amino-terminal one-third of PV 2B, i.e. the region upstream 
of the hydrophobic domains, and the remainder of CBV3 2B. 
Remarkably, a hybrid protein that contained the amino- 
terminal one-third of CBV3 2B and the remainder of PV 2B 
(2B/PV34-99) was non-functional. The loss of activity of this 
protein may be due to a general disruption of the structure of 
either 2B or 2BC. However, this possibility seems unlikely in 
view of the correct functioning of protein 2B/PV1-30. The 
explanation that the carboxy-terminal two-thirds of the protein 
contains the sequence-specific determinants required for an 
intramolecular interaction with 2C (in precursor 2BC) or for 
intermolecular contacts with other viral replication proteins 
seems more plausible and is in agreement with the non- 
functioning of PV 2B in vRNA replication, as discussed above.
Hybrid genomes that contained the cationic amphipathic cc-
helix of PV 2B (2B/PV34-59, 2B/PV37-54, 2B/PV1-59) failed
to replicate. This is in agreement with the previously described 
defect in vRNA replication of 2B-bomII, a chimeric CBV3 
genome that produced a 2B protein in which the cationic 
amphipathic helix was replaced with a similar motif of the lytic 
peptide bombolitin II (van Kuppeveld et al, 1996 a). The 
amphipathic helix motif in CBV3 2B is a major determinant for 
the ability to modify membrane permeability and inhibit 
protein secretion (van Kuppeveld et al, 199la, b). The
occurrence of such a motif is characteristic for membrane- 
disrupting proteins. Two models of action have been proposed 
to explain the membrane-perturbing activities of these proteins 
(Bernheimer & Rudy, 1986; Shai, 1995). According to the first 
model, the amphipathic helix lies collateral to the membrane 
and inserts a few Angstroms into it, thereby making the 
membrane phospholipids more susceptible to degradation by 
phospholipases. The second model suggests that the amphi­
pathic helices form aqueous pores by spanning the membrane 
and forming oligomers, exposing their hydrophobic faces to 
the lipid bilayer and their hydrophilic faces forming the 
aqueous interior. The non-exchangeability of the amphipathic 
helix argues against an independent role (i.e. the first model) of 
this domain in the structure and function of 2B, The reason for 
the non-functioning of these hybrid 2B proteins is unknown. A 
possible explanation is that the amphipathic helix and the 
second hydrophobic domain of CBV3 2B are cooperatively 
involved in the formation of membrane-integral pores. 
Disturbances of contacts between these two domains may also 
account for the nonviability of the constructs that contained 
the amphipathic helix of CBV3 2B but the second hydrophobic 
domain of PV 2B (2B/PV60-99, 2B/PV60-94). Alternatively, 
the non-functioning of these hybrid proteins may be due to 
general disruption of 2B structures.
In conclusion, these studies have allowed us to separate the 
contribution of distinct domains to the function of protein 2B 
in vRNA replication. We have shown that the amino-terminal 
one-third of CBV3 2B, but not the middle one-third or the 
carboxy-terminal one-third of the protein, neither alone nor in 
combination, can be functionally replaced with its PV counter­
part. In contrast to the carboxy-terminal two-thirds of the 
protein, the role of the amino-terminal region in the function of 
2B protein is yet unclear. Mutations in this region caused 
defects in vRNA replication (Johnson & Sarnow, 1991), but did 
not interfere with the ability of protein 2B to inhibit protein 
secretion (van Kuppeveld et al, 1997a). Recently, it has been 
shown that deletion of the first 30 amino acids of protein 2B 
abolished the ability of PV protein 2BC to induce membrane 
proliferation and to interfere with the exocytic pathway in 
yeast cells (Barco & Carrasco, 1995). The importance of this 
region for a function of protein 2B, or 2BC, in mammalian cells 
awaits further investigation.
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